. 2021 Sep 15;11(9):4329–4346.

Table 2.

Association between HOXC6 or miR-27a expression and the clinicopathological characteristics of patients with NSCLC

Clinical Characteristics	n	HOXC6		P	miR-27a		P

		Low (n=52)	High (n=41)		Low (n=57)	High (n=36)
Gender				0.412^a			0.047^a ^*
Male	50	26	24		26	24	0.049^b ^*
Female	43	26	17		31	12
Age (year)				0.015^a ^*			0.501^a
>60	45	31	14	0.015^b ^*	26	19
≤60	48	21	27		31	17
Location				0.69^a			0.842^a
Left	38	22	16		24	14
Right	54	29	25		33	21
Unknown	1	1	0		0	1
Tumor size(cm)				0.763^a			0.934^a
>3	46	25	21		28	18
≤3	47	27	20		29	18
Lymphatic invasion				0.005^a ^*			0.042^a ^*
Lymphatic invasion				0.005^b ^*			0.043^b ^*
Present	14	3	11		12	2
Absent	79	49	30		45	34
AJCC stage				0.007^a ^*			0.043^a ^*
1~2	45	30	15	0.007^b ^*	23	22	0.044^b ^*
3~4	31	11	20		23	8
Unknown	17	11	6		11	6
Pathological grade				0.765^a			0.316^a
I~II	65	37	28		42	23
III	28	15	13		15	13
Status				0.258^a			0.808^a
Survival	22	10	12		13	9
Death	71	42	29		44	27

Pearsoν χ² test;

Fisher’s Exact Test;

P<0.05.